Our site uses cookies to improve the contents of the site and customize it according to individual use. Please confirm that you agree to our use of cookies by clicking Yes.

If you continue without explicit consent, we will assume that you agree to our cookie policy.

MEDISOA comprehensive portal site for
Medical Innovation Support Office (MEDISO).Medical Innovation Support Office

厚生労働省

現在の相談業務状況について

MEDISOはテレワークで相談業務を継続しています。この機会に是非事業計画や製品化計画の粒度をあげるためにご活用ください。無料相談・お問い合わせはこちら

Knowledgeable experts support the practical application of medicines, medical devices, and regenerative medicinal products.

現在の相談業務状況について

MEDISOはテレワークで相談業務を継続しています。この機会に是非事業計画や製品化計画の粒度をあげるためにご活用ください。無料相談・お問い合わせはこちら

2019年12月28日(土)~2020年1月5日(日)は、年末年始冬季休業とさせていただきます。
この期間中にお受けしたお問い合せ・ご相談の申込みについては、休業明けに対応させていただきます。
何卒ご了承のほどお願いいたします。

2019.10.01飛び込み相談窓口「MEDISO Open Hours」開設のご案内

NEWS

飛び込み相談窓口「MEDISO Open Hours」を開設いたします。 ※5月中は中止とさせていただきます

2020.03.18出前相談会 in 京都 イベントレポート

REPORT

2020年1月20日に開催された「MEDISO出前相談会 in 京都」のレポートです。

2020.03.18MEDISO相談企業が「未来2020」の「GAP GRANT “MIRAI”」を受賞しました

NEWS

MEDISO相談企業である株式会社iMed Technologies様が、III(トリプルアイ)の主催するインキュベーション・アクセラレーションプログラム「未来2020」において、賞金付きの賞である「GAP GRANT “MIRAI”」を受賞されました。

2020.04.16MEDISO相談企業の事業において共同事業化契約の締結が決定しました。

NEWS

MEDISOにご相談いただきましたジーンテクノサイエンス社の事業において、共同事業化契約の締結が決定しました。

お知らせをもっと見る

What is MEDISO

MEDISO provides support for business ventures, academia,
and individuals intending to put into practical use medicines,
medical devices, and regenerative medicinal products.
Click here for further details.

About the Medical Innovation Support Office

The medical innovation support office matches medical venture companies and academic institutions facing challenges in the practical application of medical products and devices for specialists* who provide detailed consultation and support for solving problems at each stage from research and development to practical use, as well as insurance coverage at clinical sites, while looking ahead to the overall comprehensive advances and dissemination into the global market.
* Specialists in each field provide support for the response to laws and regulations, marketing, business planning, fund rasing, management strategy, intellectual property management, and international development, etc.

This website is operated by Mitsubishi Research Institute, Inc., as a trustee under instructions from the Economic Affairs Division, Health Policy Bureau, and Ministry of Health, Labour and Welfare as a part of the total support for the medical ventures program sponsored by the Ministry of Health, Labour and Welfare.

Support targets

Ventures, academic institutions, and individuals aiming to put into practical use the medicines, medical devices, regenerative medicinal products, and novel drug-discovery technologies or medical materials subject to the Pharmaceuticals and Medical Devices Law.

Details of support

MEDISO provides support for the practical application of medicines, medical devices, regenerative medicinal products, and other products subject to the Pharmaceuticals and Medical Devices Law.
That support includes business planning, financing, advice on laws and regulations, and other assistance as required.

Click here for inquiries and consultation requests

Specialists Introduction

We will introduce registered specialists
(updated as necessary).

Makoto Shigematsu

Representative Director, Kai Fostering Partners Inc.

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Marketing
  • Business planning
  • Funding
  • Business operation systems
  • Specialized support fields

He worked on a new project research and development, trial manufacture, mass production, and commercializing of glass delay line element for VTR at Asahi Glass Co., Ltd. He moved to CSKVC by making use of his relevant experience. As a venture capitalist, he engaged mainly in establishing, financing, fostering, and managing venture companies. He practiced monetizing of novel technologies, timely financing, establishing organization and management, sharing an exit strategy as a milestone, active use of intellectual property rights (open and close), and business talks and negotiations (not bargaining) hated by engineers. He has providing support for company’s growth fostered by competition and cooperation, while being employed by traditional companies for 20 years and by venture companies for 20 years with an understanding exactly the opposite of the corporate culture of both.

Katsuya Hashizume

Leader of the Group for Investment Through Collaboration Between Industry and Academia, JAFCO Co., Ltd.

Main specialty areas

  • medical devices

Specialized support fields

  • Marketing
  • Business planning
  • Funding
  • Business operation systems
  • Specialized support fields

After graduating with a master’s degree from the Graduate School of Media and Governance, Keio University, he joined JAFCO Co., Ltd. Since he joined the company, he has consistently engaged in investment in university-launched venture companies. He made several investments in life science companies (gene analysis, diagnostic devices such as POCT, surgery support robots, medical devices such as those for cerebrovascular thrombectomy, regenerative medicine, and bioinformatics) at the seed or early stage in the company’s lifecycle. He also holds the positions of outside director of multiple university-launched venture companies. He is working on commercializing the technology seeds possessed by research institutes such as universities as a representative project promoter of the Program for Creating Start-ups from Advanced Research and Technology (START) operated by the Japan Science and Technology Agency (JST).

Bunsei Kawakami

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Regulatory compliance
  • Marketing
  • Business planning
  • Business operation systems
  • Specialized support fields

He graduated with a master’s degree from the Division of Agricultural Chemistry, Graduate School of Agriculture, Kyoto University. He holds a doctoral degree in agriculture. He was in a department for healthcare project in a private company for 31 years, where he was involved in product development and marketing of chemical reagents and devices for life science research and in vitro diagnostic reagents and devices. After retirement, he worked for a public industry support organization for five years, where he supported product development (including intellectual property and response to laws and regulations) and sales channel development (including overseas) promoted by companies aiming to newly enter the healthcare business. He hopes to provide support for product development and sales channel development of medical venture companies by using his knowledge, experience, and human network of connections that he has gained through these business activities.

Yukari Kume

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Etc

She graduated with a master’s degree from the Graduate School of Philosophy, Sophia University. After studying in the US for three years, she returned to Japan to work as an interpreter and translator of English at a semiconductor manufacturer and an IT company for more than 10 years. In 2012, she joined Mitsubishi Research Institute, Inc., to translate technology into English and was involved in surveys of overseas laws and regulations and the technical regulations governing suitability assessment and authorizations in the fields of railways, aircrafts, and consumer products. From November 2015, she has provided various types of surveys as a freelance consultant.

Hirofumi Usami

Intellectual Property Strategy Advisor, Intellectual Property Strategy Network, Inc.

Main specialty areas

  • medicines
  • medical devices
  • regenerative medicine products

Specialized support fields

  • Specialized support fields

Work Experience: He successively held the following positions: Patent License GM in Intellectual Property Department of Takeda Pharmaceutical Company Limited; a permanent member of Industrial Property Right Committee of Osaka Pharmaceutical Industries Association; a visiting professor at the Graduate School of Law, Kyoto University; Director Responsible for Industry of Japan Intellectual Property Association; a visiting professor in the Dept. of Science and Technology Law, National Yunlin University of Science and Technology (Taiwan); and a professor at the Graduate School of Intellectual Property, Osaka Institute of Technology. From 2013, he became an advisor at Intellectual Property Strategy Network, Inc.

His book: Patent Strategies Necessary to Develop Your Company
His Paper: Yakugaku Zasshi, Patent Management, Pharm Stage, International pharmaceutical intelligence, Research on Intellectual Property, Tokugikon, Intellectual property management, Pharm Tech Japan, Science & industry, etc.

About details of specialists

Introduction of measures implemented by public institutions

We will describe the measures from public institutions for pharmaceutical companies,
medical device companies, companies manufacturing regenerative medicinal products, and venture companies.

See more about measures implemented by public institutions